Cytotoxic T cell (activation)

"Killer T cell activation" most precisely refers to the process by which cytotoxic T lymphocytes (also called killer T cells or CD8+ T cells) become activated after recognizing antigenic peptides presented on MHC-I molecules of antigen-presenting cells. This process, essential for adaptive immunity, requires T cell receptor (TCR) engagement, co-stimulation (e.g., via CD28), and in many cases, cytokine signaling (notably interleukin-2). Upon full activation, cytotoxic T cells acquire the ability to kill infected or transformed cells by releasing cytotoxic granules containing perforin and granzymes or by engaging death receptors such as Fas on target cells, leading to apoptosis. The molecules and pathways involved in CTL activation, rather than the activation process itself, are typical drug targets, particularly in immuno-oncology and autoimmune disease,[1][2][3][4][5] but "killer T cell activation" by itself does not denote a distinct molecular target.\n\nImportant notes:\n- "Killer T cell activation" does not refer to a discrete molecule, receptor, or protein, but rather to a cellular process involving several molecules and pathways[1][2][4].\n- The actual therapeutic targets involved in this process are the cell surface receptors and pathways mediating activation (e.g., T cell receptor, CD3 complex, CD28, PD-1, CTLA-4), not the activation process as a whole[2].\n- Interacting drugs modulate components of the activation process (e.g., checkpoint inhibitors target PD-1/PD-L1 or CTLA-4), but do not target "killer T cell activation" as a singular entity.\n\nConclusion:\nThe name as provided ("Killer T cell activation") is not a valid molecular drug target; it describes a process rather than a specific molecule, and thus should be marked as "is_incorrect: true". For drug targeting and structured databases, refer instead to the cellular effectors (like CD8, T cell receptor complex, or specific costimulatory/inhibitory molecules) involved in T cell activation.

Other names

Killer T cellCD8+ T cell

Induction of cytotoxicity via perforin/granzyme pathway\nInduction of apoptosis via Fas/FasL pathway